Mirum Pharmaceuticals (MIRM) Consolidated Net Income: 2020-2025
Historic Consolidated Net Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $2.9 million.
- Mirum Pharmaceuticals' Consolidated Net Income rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
- Mirum Pharmaceuticals' Consolidated Net Income amounted to $2.9 million in Q3 2025, which was up 149.56% from -$5.9 million recorded in Q2 2025.
- Mirum Pharmaceuticals' Consolidated Net Income's 5-year high stood at $57.3 million during Q4 2021, with a 5-year trough of -$74.0 million in Q2 2023.
- Moreover, its 3-year median value for Consolidated Net Income was -$23.8 million (2024), whereas its average is -$24.5 million.
- Per our database at Business Quant, Mirum Pharmaceuticals' Consolidated Net Income skyrocketed by 253.52% in 2021 and then tumbled by 175.01% in 2023.
- Mirum Pharmaceuticals' Consolidated Net Income (Quarterly) stood at $57.3 million in 2021, then slumped by 163.60% to -$36.4 million in 2022, then rose by 2.12% to -$35.7 million in 2023, then soared by 33.28% to -$23.8 million in 2024, then skyrocketed by 120.41% to $2.9 million in 2025.
- Its Consolidated Net Income was $2.9 million in Q3 2025, compared to -$5.9 million in Q2 2025 and -$14.7 million in Q1 2025.